ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia

An increase in the prevalence of allergic rhinitis (AR) worldwide presents a significant burden to the health care system. An initiative was started in Europe designated as Allergic Rhinitis and Its Impact on Asthma (ARIA) to develop internationally applicable guidelines by utilising an evidence-based approach to address this crucial issue. The efforts are directed at empowerment of patients for self-management, the use of digital mobile technology to complement and personalise treatment, and establishment of real-life integrated care pathways (ICPs). This guideline includes aspects of patients’ and health care providers’ management and covers the main areas of treatment for AR. The model provides better real-life health care than the previous traditional models. This review summarises the ARIA next-generation guideline in the context of the Malaysian health care system.

[1]  R. Pawankar,et al.  Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis , 2023, Journal of clinical medicine.

[2]  S. Subha,et al.  Prevalence, causes and treatments of allergic rhinitis in Malaysia: a literature review , 2022, The Egyptian Journal of Otolaryngology.

[3]  B. Abdullah,et al.  Medication Adherence to Intranasal Corticosteroids in Allergic Rhinitis Patients with Comorbid Medical Conditions , 2022, Pharmaceutics.

[4]  B. Abdullah,et al.  Reshaping the Management of Allergic Rhinitis in Primary Care: Lessons from the COVID-19 Pandemic , 2022, International journal of environmental research and public health.

[5]  R. Mösges,et al.  Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology , 2022, Journal of asthma and allergy.

[6]  R. Metson,et al.  Endoscopic sinus surgery for chronic rhinosinusitis: 22‐item Sino‐Nasal Outcome Test 5‐year results , 2021, International forum of allergy & rhinology.

[7]  B. Abdullah,et al.  Surgical Interventions for Inferior Turbinate Hypertrophy: A Comprehensive Review of Current Techniques and Technologies , 2021, International journal of environmental research and public health.

[8]  O. Pfaar,et al.  Anti-IgE: A treatment option in allergic rhinitis? , 2021, Allergologie select.

[9]  S. Chua,et al.  The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study , 2020, BMC Health Services Research.

[10]  D. Wang,et al.  Primary care management of allergic rhinitis: a cross-sectional study in four ASEAN countries , 2020, Multidisciplinary respiratory medicine.

[11]  A. Sheikh,et al.  Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases , 2019, Clinical and Translational Allergy.

[12]  Airways ICPs initiative,et al.  ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project , 2019 .

[13]  A. Sheikh,et al.  Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. , 2019, The Journal of allergy and clinical immunology.

[14]  C. Pitsios,et al.  Ways to increase adherence to allergen immunotherapy , 2019, Current medical research and opinion.

[15]  A. Sheikh,et al.  2019 ARIA Care pathways for allergen immunotherapy , 2019, Allergy.

[16]  J. Bousquet,et al.  Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases , 2019, Clinical and Translational Allergy.

[17]  D. Price,et al.  Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. , 2019, The Journal of allergy and clinical immunology.

[18]  Todor A Popov,et al.  ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy” , 2019, Allergy.

[19]  Rosalind W. Picard,et al.  MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence , 2018, Clinical and Translational Allergy.

[20]  Y. Okamoto,et al.  Efficacy and safety of SQ house dust mite sublingual immunotherapy‐tablet in Japanese children , 2018, Allergy.

[21]  Daniel Laune,et al.  POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project , 2018, Clinical and Translational Allergy.

[22]  A. Sheikh,et al.  Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study , 2018, Allergy.

[23]  S. Durham,et al.  Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis , 2018, Current Treatment Options in Allergy.

[24]  Boleslaw Samolinski,et al.  Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  A. Sheikh,et al.  Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study , 2018, Allergy.

[26]  C. Janson,et al.  Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007–2012 , 2018, Clinical and Translational Allergy.

[27]  A. Sheikh,et al.  EAACI guidelines on allergen immunotherapy: Executive statement , 2018, Allergy.

[28]  A. Sheikh,et al.  Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy , 2018, Allergy.

[29]  A. Sheikh,et al.  EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis , 2018, Allergy.

[30]  A. Sheikh,et al.  The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study , 2018, Allergy.

[31]  A. Sheikh,et al.  Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project , 2018, Allergy.

[32]  P. Devillier,et al.  Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis , 2017, Allergy.

[33]  E. Valovirta,et al.  Results from the 5‐year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy , 2017, The Journal of allergy and clinical immunology.

[34]  E. Meltzer,et al.  Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  G. Canonica,et al.  Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial , 2017, Clinical and Translational Allergy.

[36]  A. Sheikh,et al.  EAACI guidelines on allergen immunotherapy: Prevention of allergy , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[37]  Joaquim Mullol,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.

[38]  J. Bousquet,et al.  Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report , 2017, Clinical and Translational Allergy.

[39]  A. Sheikh,et al.  Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[40]  Todor A Popov,et al.  ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.

[41]  Todor A Popov,et al.  MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. , 2016, The Journal of allergy and clinical immunology.

[42]  S. Sararaks,et al.  Improving Health Care Coverage, Equity, And Financial Protection Through A Hybrid System: Malaysia's Experience. , 2016, Health affairs.

[43]  M. Woodward,et al.  Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. , 2016, JAMA internal medicine.

[44]  R. Lockey,et al.  Solving the Problem of Nonadherence to Immunotherapy. , 2016, Immunology and allergy clinics of North America.

[45]  J. Bousquet,et al.  Allergen Immunotherapy (AIT): a prototype of Precision Medicine , 2015, The World Allergy Organization journal.

[46]  F. Rodenas,et al.  MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation , 2015, Allergy.

[47]  J. Romualdez,et al.  Attitudes, practices on allergic rhinitis of generalists and specialists in Philippine National Capital Region , 2015, Asia Pacific allergy.

[48]  M. Illario,et al.  Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population , 2015, Journal of aging research.

[49]  P. Demoly,et al.  Clinical contraindications to allergen immunotherapy: an EAACI position paper , 2015, Allergy.

[50]  Shu-chuen Li,et al.  Quality use of medicine in a developing economy: Measures to overcome challenges in the Malaysian healthcare system , 2015, SAGE open medicine.

[51]  R. Naidu,et al.  Clinical manifestation and sensitization of allergic children from Malaysia , 2015, Asia Pacific allergy.

[52]  J. Bousquet,et al.  MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. , 2015, World hospitals and health services : the official journal of the International Hospital Federation.

[53]  H. Sitter,et al.  Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases , 2014, Allergo Journal International.

[54]  M. Blaiss,et al.  Current Allergic Rhinitis Experiences Survey (CARES): Health-care practitioners' awareness, attitudes and practices. , 2014, Allergy and asthma proceedings.

[55]  D. Postma,et al.  Integrated care pathways for airway diseases (AIRWAYS-ICPs) , 2014, European Respiratory Journal.

[56]  J. Bousquet,et al.  Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. , 2014, Allergy.

[57]  J. Bousquet,et al.  Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. , 2013, The Journal of allergy and clinical immunology.

[58]  L. Falzon,et al.  Treatments for Seasonal Allergic Rhinitis , 2013 .

[59]  J. Bousquet,et al.  Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? , 2013, Allergy.

[60]  M. Blaiss,et al.  Asthma burden in the United States: results of the 2009 Asthma Insight and Management survey. , 2012, Allergy and asthma proceedings.

[61]  Holger J Schünemann,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.

[62]  H. Iro,et al.  Septoplasty outcome in patients with and without allergic rhinitis. , 2009, Rhinology.

[63]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[64]  Erkka Valovirta,et al.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.

[65]  S. Chesrown,et al.  Adherence to Oral Montelukast and Inhaled Fluticasone in Children with Persistent Asthma , 2001, Pharmacotherapy.

[66]  A. Razak,et al.  Prevalence of asthma, rhinitis and eczema among schoolchildren in Kelantan, Malaysia , 1997, Acta paediatrica Japonica : Overseas edition.